Soleil Securities Downgrades Myriad Genetics (MYGN) to Hold; Rich Valuation and Headline Risks
Tweet Send to a Friend
Soleil Securities downgraded Myriad Genetics (NASDAQ: MYGN) from Buy to Hold. PT lowered $2 to $20.
Soleil analyst says, "Our ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Soleil analyst says, "Our ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
